Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01705587 · ClinicalTrials.gov registry record · Phase 4
Fracture (FX) Improvement With Teriparatide: FiX-IT Study
A Phase 4 study, sponsored by Susan L. Greenspan.
- Completed
- Registry status
- Phase 4
- Development phase
- 13
- Enrollment target
NCT01705587 is a Phase 4 study that has completed, run by Susan L. Greenspan. The registered enrollment target is 13 participants.
The verdict
NCT01705587, a Phase 4 study, has completed, sponsored by Susan L. Greenspan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 13 participants
- Enrollment target
Study Summary
This open label comparison study examines the hypothesis that teriparatide given immediately following repair of an atypical subtrochanteric or diaphyseal femoral shaft fracture will enhance healing and improve bone mineral density compared to delayed treatment (after six months) with teriparatide or no treatment with teriparatide (patients who refuse therapy or for whom teriparatide is contraindicated). Patients with up-front teriparatide in addition will have greater quality of life measures and less pain compared to those with delayed or no therapy.
Interventions
- DRUG teriparatide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2012-12 |
| Est. Completion | 2016-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01705587
The ClinicalTrials.gov registry entry for NCT01705587 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Susan L. Greenspan, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which teriparatide is the first listed.
NCT01705587 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01705587 about?
NCT01705587 is a clinical study titled "Fracture (FX) Improvement With Teriparatide: FiX-IT Study". This open label comparison study examines the hypothesis that teriparatide given immediately following repair of an atypical subtrochanteric or diaphyseal femoral shaft fracture will enhance healing and improve bone mineral density compared to delayed treatment (after six months) with teriparatide o...
What is the current status of trial NCT01705587?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 13 participants. The study started on 2012-12. Estimated completion is 2016-09.
What interventions are being tested in trial NCT01705587?
The interventions under investigation include: teriparatide (DRUG).
Who is sponsoring clinical trial NCT01705587?
This trial is sponsored by Susan L. Greenspan, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.